Finance

Lists
NKGN:OTCMKTS
NKGen Biotech Inc
0,011 USD
0,00%
(0,00) 1D
20-окт., 15:04:48 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NKGN...
Open
0,01 USD
High
0,01 USD
Low
0,01 USD
Mkt. cap
1,58 млн
Avg. vol.
3,33 миң
Volume
375,00
52-wk high
0,20 USD
52-wk low
0,00 USD
Beta
1,69
Shares outstanding
130,60 млн
No. of employees
26
Open
0,01 USD
High
0,01 USD
Low
0,01 USD
Mkt. cap
1,58 млн
Avg. vol.
3,33 миң
Volume
375,00
52-wk high
0,20 USD
52-wk low
0,00 USD
Beta
1,69
Shares outstanding
130,60 млн
No. of employees
26
News stories
From web sources and news partners
About NKGen Biotech Inc
CEO-
Employees26
Founded2017
HeadquartersСанта Ана, Калифорния, Америка Кошмо Штаттары
Sector-
Websitenkgenbiotech.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2024-ж. сен.
2024-ж. дек.
2025-ж. мар.
Revenue
-
-
-
Cost of goods sold
-
-
-
Cost of revenue
-
-
-
Research and development expenses
2,78 млн
1,56 млн
1,86 млн
Total research and development expenses
-
-
-
Selling, general, and admin expenses
4,01 млн
3,54 млн
2,81 млн
Operating expense
6,79 млн
5,10 млн
4,67 млн
Total operating expenses
6,79 млн
5,10 млн
4,67 млн
Operating income
-6,79 млн
-5,10 млн
-4,67 млн
Other non operating income
-2,99 млн
-8,79 млн
20,52 млн
EBT including unusual items
6,60 млн
-29,36 млн
15,35 млн
EBT excluding unusual items
-10,25 млн
-14,43 млн
15,35 млн
Income tax expense
-
53,00 миң
-
Effective tax rate
-
-0,18%
-
Other operating expenses
-
-
-
Net income
6,60 млн
-29,41 млн
15,35 млн
Net profit margin
-
-
-
Earnings per share
-
-
-
Interest and investment income
-
-
-
Interest expense
-472,00 миң
-536,00 миң
-509,00 миң
Net interest expenses
-472,00 миң
-536,00 миң
-509,00 миң
Depreciation and amortization charges
-
-
-
EBITDA
-6,49 млн
-4,80 млн
-4,32 млн
Gain or loss from assets sale
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору